BioAge Labs Investor Relations Material

BioAge Labs Inc. is a biotechnology company focused on developing therapies to extend healthy human lifespan by targeting the biological pathways of aging. The company utilizes a proprietary platform that combines machine learning, genomics, and biomarker analysis to identify and develop drug candidates aimed at treating age-related diseases, such as those affecting muscle health, immune function, and metabolism. BioAge Labs conducts research to address the underlying biological factors of aging with the goal of improving health outcomes in later life. The company is headquartered in Richmond, California, and its shares are listed on the Nasdaq.